Estrogen-dependent activity of kidney lysosomal proteolytic enzymes

E Radzikowska1, K Janicki, R Maciejewski

  • 1Human Anatomy Department, Medical University of Lublin.

Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina
|April 30, 2002
PubMed

Insights

Long-term estrogen use can alter kidney lysosomal enzymes, including cathepsin B, D, and L. While significant changes were observed, they were uncharacteristic and showed no clear dose-response relationship in female rats.

Area of Science:

  • Biochemistry
  • Toxicology
  • Endocrinology

Background:

  • Drug-induced kidney injury is a recognized complication of various medications.
  • Widespread use of estrogens in oral contraceptives and hormone replacement therapy necessitates understanding their effects on kidney function.
  • Estrogen's impact on kidney biochemical alterations, particularly enzyme induction, requires detailed investigation.

Purpose of the Study:

  • To evaluate the influence of long-term estrogen exposure on kidney lysosomal enzymes.
  • Specifically assess the activity of cathepsin B, D, and L in female rats following estrogen administration.

Main Methods:

  • Female rats were divided into eight groups, including untreated and vehicle-treated controls.
  • Oestradiolum benzoicum was administered intramuscularly weekly or every three days for eight weeks at varying doses.
  • Activity of free and bound fractions of lysosomal enzymes (cathepsin B, D, L) was measured in kidney homogenates using spectrophotometry.
  • Statistical analysis was performed using the ANOVA test.

Main Results:

  • Significant changes in the activity of cathepsin B, D, and L fractions were observed compared to control groups.
  • The most pronounced changes were noted in the activity of cathepsin B and D.
  • Differences in enzyme activity were detected even at the lowest estrogen dose compared to controls.
  • No direct correlation was found between the administered estrogen dose and the observed changes in lysosomal enzyme activity.
  • The observed alterations in lysosomal activity were generally uncharacteristic.

Conclusions:

  • Long-term estrogen administration can induce changes in kidney lysosomal enzyme activity.
  • The observed effects on cathepsin B, D, and L are complex and not consistently dose-dependent.
  • Further research is needed to fully elucidate the mechanisms and clinical implications of estrogen-induced kidney alterations.

Related Concept Videos

The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...